ROSIELLO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 1.983
AS - Asia 1.508
NA - Nord America 1.245
SA - Sud America 411
AF - Africa 48
Totale 5.195
Nazione #
RU - Federazione Russa 1.248
US - Stati Uniti d'America 1.186
SG - Singapore 577
CN - Cina 413
BR - Brasile 320
SE - Svezia 224
HK - Hong Kong 191
VN - Vietnam 171
IT - Italia 119
DE - Germania 95
FR - Francia 86
GB - Regno Unito 57
IN - India 51
FI - Finlandia 48
AR - Argentina 39
CA - Canada 28
NL - Olanda 28
PL - Polonia 25
BD - Bangladesh 23
MX - Messico 23
ZA - Sudafrica 19
ID - Indonesia 15
IQ - Iraq 15
EC - Ecuador 14
JP - Giappone 13
PE - Perù 12
AT - Austria 9
CO - Colombia 8
ES - Italia 8
IE - Irlanda 7
LT - Lituania 7
MA - Marocco 7
TR - Turchia 7
UZ - Uzbekistan 7
VE - Venezuela 7
EG - Egitto 5
PK - Pakistan 5
TN - Tunisia 5
UA - Ucraina 5
BE - Belgio 4
CL - Cile 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JO - Giordania 2
PH - Filippine 2
RO - Romania 2
AO - Angola 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UG - Uganda 1
Totale 5.195
Città #
Singapore 313
Moscow 212
Ashburn 190
Hong Kong 189
Dallas 172
San Jose 108
Shanghai 100
New York 74
Hefei 68
Ho Chi Minh City 66
Lauterbourg 56
Boardman 50
Lawrence 50
Princeton 50
Beijing 48
Los Angeles 47
Munich 35
Milan 34
Hanoi 32
Helsinki 26
São Paulo 26
Warsaw 20
Turku 19
Orem 18
Frankfurt am Main 17
Brooklyn 16
Manchester 16
Phoenix 16
Johannesburg 15
Santa Clara 15
Denver 14
Rome 14
Chennai 13
Haiphong 13
Montreal 13
Rio de Janeiro 13
Atlanta 12
Houston 12
Guangzhou 11
Tokyo 11
Chicago 10
Lima 10
Mexico City 10
Mumbai 10
Poplar 10
Toronto 9
Amsterdam 8
Nuremberg 8
Belo Horizonte 7
Brasília 7
Columbus 7
Falkenstein 7
Hyderabad 7
Shenzhen 7
The Dalles 7
Washington 7
Barnet 6
Biên Hòa 6
Council Bluffs 6
Da Nang 6
Dhaka 6
Dronten 6
Dublin 6
London 6
Manaus 6
Stockholm 6
Tashkent 6
Pune 5
Querétaro 5
Quito 5
Vienna 5
Borås 4
Boston 4
Brussels 4
Duque de Caxias 4
Guayaquil 4
Hải Dương 4
Ipatinga 4
Jiaxing 4
Ribeirão Preto 4
Salvador 4
Seattle 4
Wroclaw 4
Ahmedabad 3
Annapolis 3
Baghdad 3
Belford Roxo 3
Bogotá 3
Buffalo 3
Campinas 3
Canoas 3
Casablanca 3
Cleveland 3
Erbil 3
Guarulhos 3
Hangzhou 3
Hưng Yên 3
Itumbiara 3
Karbala 3
Kyiv 3
Totale 2.540
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 176
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 162
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 124
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 121
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 118
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 116
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 116
Pulmonary lesion after surgery for renal cancer: progression or new primary? 112
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 111
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 110
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 109
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 109
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 107
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 107
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 107
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 107
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 102
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 101
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 99
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 98
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 93
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 92
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 88
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 86
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer 82
Bladder cancer incidence rates and trends in young adults aged 20-39 years 81
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 81
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 80
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer 80
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium 79
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 77
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 76
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 76
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study 76
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 75
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 75
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 73
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 73
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 68
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 67
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA 59
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 59
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 59
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 58
Erratum: Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010 (European urology oncology PII: S2588-9311(23)00237-7) 57
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 56
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 56
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 55
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 54
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 53
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 51
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 50
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 49
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy 49
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder 48
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 47
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma 47
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 45
Re: Stamatio Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920–9 44
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 44
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 43
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 43
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 43
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 42
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 42
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines 42
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 40
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 38
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 34
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer Patients 3
Totale 5.300
Categoria #
all - tutte 28.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202233 0 2 2 13 2 1 0 0 1 0 1 11
2022/2023358 131 84 35 5 6 42 6 29 15 0 1 4
2023/2024334 20 20 29 21 20 52 8 61 7 9 17 70
2024/20251.034 111 42 54 45 31 79 125 102 134 135 77 99
2025/20263.496 255 244 264 460 323 100 266 320 1.084 180 0 0
Totale 5.300